Results 11 to 20 of about 200,594 (216)
Indian Journal of Endocrinology and Metabolism, 2014 Aim: To determine the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) therapy in the Indian patients with type 2 diabetes previously on basal or basal-bolus insulin therapies.
Arpandev Bhattacharyya +3 more
doaj +1 more source
Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?
Indian Journal of Endocrinology and Metabolism, 2015 Over the past few decades, continuous progress has been made in the development of insulin therapy. Basal insulins were developed around 60 years ago. However, existing basal insulins were found to have limitations. An ideal basal insulin should have the
Sanjay Kalra
doaj +1 more source
Modern basal insulin analogs: An incomplete story
Indian Journal of Endocrinology and Metabolism, 2014 The currently available basal insulin does not completely mimic the endogenous insulin secretion. This has continued to promote the search for ideal basal insulin.
Awadhesh Kumar Singh +1 more
doaj +1 more source
Annals of Medicine, 2021 Many patients with type 2 diabetes will ultimately require the inclusion of basal insulin in their treatment regimen. Since most people with type 2 diabetes are managed in the community, it is important that primary care providers understand and ...
Roopa Mehta +3 more
doaj +1 more source
Frontiers in Endocrinology, 2018 Background: Basal and premixed insulin have been widely used for insulin therapy of type 2 diabetes mellitus (T2DM) in China. The aim of this study is to compare the sustained efficacy of basal and premixed insulin therapies in T2DM outpatients with ...
Guangxu Liu +14 more
doaj +1 more source
Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes
Sensors, 2021 Technology advances have made possible improvements such as Continuous Glucose Monitors, giving the patient a glucose reading every few minutes, or insulin pumps, allowing more personalized therapies.
Jesús Berián +4 more
doaj +1 more source
Modern basal insulins: an ongoing story or the start of a new era?
Сахарный диабет, 2015 Basal insulin represents an essential tool in the treatment of both type 1 and type 2 diabetes mellitus. The development of insulin analogues has improved the possibilities of diabetes treatment.
Ivan Ivanovich Dedov
doaj +1 more source
Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids
Pediatric Blood &Cancer, EarlyView.ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz +12 more
wiley +1 more source
79. Basal-bolus insulin compared to premixed insulin in cardiac outpatients with type 2 diabetes
Journal of the Saudi Heart Association, 2016 Diabetes is a highly prevalent chronic disease worldwide. It was observed inKing Abdul-Aziz Cardiac Centre (KACC) that, subjects treated with basal bolus insulin showed better glycemic control than premixed insulin.
A. Enoz
doaj +1 more source
Metabolites, 2021 Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec and 30% insulin aspart. The present meta-analysis was conducted to assess the efficacy and safety of IDegAsp compared with a conventional premixed insulin or ...
Shinje Moon +6 more
doaj +1 more source